TrialReviewer
Evidence Appraisal for Clinical Trials
AI tools summarize what a trial says. They rarely tell you whether the result actually holds up. TrialReviewer does that appraisal automatically.
Share cardActual performance
Did not reach leaderboard
Launch Intel predictions
Analyze your own launch →39%39% predicted probability of success on BetaList, based on ML models trained on real launch data.
best fitHighest predicted score across all platforms for this description.
39%39% predicted probability of success on AppSumo, based on ML models trained on real launch data.
36%36% predicted probability of success on TrustMRR, based on ML models trained on real launch data.
32%32% predicted probability of success on Product Hunt, based on ML models trained on real launch data.
22%22% predicted probability of success on Acquire.com, based on ML models trained on real launch data.
16%16% predicted probability of success on Hacker News, based on ML models trained on real launch data.
12%12% predicted probability of success on Indie Hackers, based on ML models trained on real launch data.
nativeThis product was originally launched on this platform.
Correct prediction on native model
Similar products
Dr
DrugSheet – Keep up with the clinical trials on Covid-1942%Launch Intel prediction score: how likely this product is to succeed on its source platform, based on its name, tagline, and description.
DrugSheet – Keep up with the clinical trials on Covid-19
Dr
DrugSheet – Keep up with the clinical trials on Covid-1942%Launch Intel prediction score: how likely this product is to succeed on its source platform, based on its name, tagline, and description.
DrugSheet – Keep up with the clinical trials on Covid-19
TrustEscrow56%Launch Intel prediction score: how likely this product is to succeed on its source platform, based on its name, tagline, and description.
Agreements, deposits, evidence & disputes on Polygon
Scoutr29%Launch Intel prediction score: how likely this product is to succeed on its source platform, based on its name, tagline, and description.
Build with evidence, not intuition.
Ev
Evidence-based morality.20%Launch Intel prediction score: how likely this product is to succeed on its source platform, based on its name, tagline, and description.
Evidence-based morality.
Ev
Evidence-linked forensic financial investigation38%Launch Intel prediction score: how likely this product is to succeed on its source platform, based on its name, tagline, and description.
Evidence-linked forensic financial investigation
Corroso29%Launch Intel prediction score: how likely this product is to succeed on its source platform, based on its name, tagline, and description.
The evidence layer for what to build next
Op
Open access platform aggregating clinical trials for Covid-1946%Launch Intel prediction score: how likely this product is to succeed on its source platform, based on its name, tagline, and description.
Open access platform aggregating clinical trials for Covid-19
TotallyNot.ai28%Launch Intel prediction score: how likely this product is to succeed on its source platform, based on its name, tagline, and description.
Discreet clinical AI lookup for bedside clinicians
Np
Npx redential scan – evidence of your NDA work, nothing uploaded35%Launch Intel prediction score: how likely this product is to succeed on its source platform, based on its name, tagline, and description.
Npx redential scan – evidence of your NDA work, nothing uploaded